Compositions, kits, and methods relating to the human FEZ1...

Details Compositions, kits, and methods relating to the human FEZ1... Compositions, kits, and methods relating to the human FEZ1...

2006-11-28

2006-11-28

Ketter, James (Department: 1636)

Chemistry: molecular biology and microbiology

Vector, per se

C435S325000, C536S024330

Reexamination Certificate

active

07141417

ABSTRACT:
The invention relates to isolated polynucleotides homologous with a portion of one strand of the human tumor suppressor gene, FEZ1, and to the tumor suppressor protein encoded thereby, Fez1. The polynucleotides are useful, for example, as probes, primers, portions of expression vectors, and the like. The invention also includes diagnostic, therapeutic, cell proliferation enhancement, and screening methods which involve these polynucleotides and protein. The invention further includes kits useful for performing the methods of the invention.

REFERENCES:
patent: 4160452 (1979-07-01), Theeuwes
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 5210015 (1993-05-01), Gelfand et al.
patent: 5691146 (1997-11-01), Mayrand
patent: 5804177 (1998-09-01), Humphries
patent: 5840686 (1998-11-01), Chader et al.
patent: 6531456 (2003-03-01), Kurtzman et al.
patent: 0679716 (1995-06-01), None
patent: WO 01 55300 (2001-08-01), None
patent: WO 01 55448 (2001-08-01), None
Boige et al (1997) Cancer Research 57: 1986-1990.
El-Naggar et l (1998) Oncogene 16: 2983-2987.
Anbazhagan et al (1998) Am. J. Pathology 152: 815-819.
Kerangueven et al (1997) Cancer Research 57: 5469-5474.
Gustafson et al (1996) Cancer Research 56: 5238-5245.
Database Geneseq, Accession No. T23583, 1996.
Database GenEmbl, Accession No. G43056, Jan. 1999.
Wang et al (1998) Science 280:1077-1082.
Database EST, Accession No. N21184, Dec. 1995.
Database EST, Accession No. AI042490, Feb. 1999.
Ischii et al (1999) PNAS 96:3928-3922.
Lockhart et al (1996) Nature Biotechnology 14: 1675-1680.
Verma et al (1997) Nature 389:239-242.
Palù et al (1999) J. Biotechnol. 68: 1-13.
Luo et al (2000) Nature Biotechnology 18:33-37.
Ishii et al (1999) Proc Natl Acad Sci 96:3928-3933.
Database Genbank, Accession No. G43056, Wang et al.
Database Genbank, Accession No. AF123653, Ishii et al.
Database Genbank, Accession No. AF123659, Ishii et al.
Altschul, et al., 1990, J. Mol. Biol. 215:403-410.
Anbazhagan et al., 1998, Am. J. Pathol. 152:815-819.
Bec et al., 1994, J. Biol. Chem. 269:2086-2092.
Boige et al., 1997, Cancer Res. 57:1986-1990.
Bookstein et al., 1997, Br. J. Urol. 79(Suppl. 1):28-36.
Bookstein, et al., 1994, Genomics 24:317-323.
Bova et al., 1996, Genomics 35:46-54.
Brown, 1992, Nature 359:24.
Cher et al., 1994, Genes Chromosom. Cancer 11:153-162.
de Wit et al., 1998, Nucl. Acids Res. 26:676-678.
Durso and Cyr, 1994, Plant Cell 6:893-905.
El-Naggar et al., 1998, Oncogene 16:2983-2987.
Fasbender et al., 1997, J. Biol. Chem. 272:6479-89.
Fodor et al., 1993, Nature 364:555-556.
Fujiwara et al., 1995, Oncogene 10:891-895.
Gustafson et al., 1996, Cancer Res. 56:5238-5245.
Hai et al., 1989, Genes Develop. 3:2083-2090.
Heid et al., 1996, Genome Res. 6:986-994.
Ichikawa et al., 1994, Cancer Res. 54:2299-2302.
Ishii et al., 1999, Proc. Natl. Acad. Sci. USA 96:3928-3933.
Janssen et al, 1988, Eur. J. Biochem. 171:119-129.
Janssen et al., 1994, J. Biol. Chem. 269:31410-31417.
Jenkins et al., 1998, Genes Chromosom. Cancer 21:131-143.
Kagan et al., 1995, Oncogene 11:2121-2126.
Kerangueven et al., 1997, Cancer Res. 57:5469-5474.
Knudson, 1993, Proc. Natl. Acad. Sci. USA 90:10914-10921.
Komiya et al., 1997, Jpn. J. Cancer Res. 88:389-393.
Kyte and Doolittle, 1982, J. Mol. Biol. 157:105-132.
Lasko et al., 1991, Ann. Rev. Genet. 25:281-314.
Lewandoski et al., 1997, Nature Genet. 17:223-225.
Li et al., 1997, Human Gene Ther. 8:1695-1700 *.
Lockhart et al., 1996, Nature Biotechnol. 14:1675-1680.
MacGrogan et al., 1996, Genomics 35:55-65.
Macoska et al., 1995, Cancer Res. 55:5390-5395.
Marchesi and Ngo, 1993, Proc. Natl. Acad. Sci. USA 90:3028-3032.
Mathur et al., 1998, Cancer 82:816-821.
Mimori et al., 1995, Cancer 75:1446-1449.
Mimori et al., 1996, Gut 38:66-70.
Moore et al., 1998, Cell Motil. Cytoskel. 41:168-180.
Nagase et al., 1998, DNA Res. 5:31-39.
Nowell, 1993, Adv. Cancer Res. 62:1-16.
Ohta et al., 1996, Cell 84:587-597.
Pease et al., 1994, Proc. Natl. Acad. Sci. USA 91:5022-5026.
Plück, 1996 Intl. J. Exp. Pathol.77:269-278.
Russ et al., 1996, J. Virol. 70:4927-4932.
Sakai et al., 1995, Biochem. Biophys. Res. Comm. 217:393-401.
Sunwoo et al., 1996, Genes Chromosom. Cancer 16:164-169.
Takeuchi et al., 1995, Cancer Res. 55:5377-5382.
Wagner et al., 1997, Am. J. Pathol. 151:753-759.
Wallraff et al., 1997, Chemtech 27(2), only pp. 22 and 23 provided.
Weinberg, 1991, Science 254:1138-1145.
Wu et al., 1997, Genes Chromosom. Cancer 20:347-353.
Yaremko et al., 1995, Genes Chromosom. Cancer 13:186-191.
Yaremko et al., 1996, Genes Chromosom. Cancer 16:189-195.
Database EMBL Online, Jul. 1, 1998, “oxo62e04.x1 Soares—NhHMPu—S1Homo sapienscDNA clone IMAGE: 1660926 3,” Database Accession No. AI042490 XP002266794.

Affiliated with

Also associated with

Rating

Compositions, kits, and methods relating to the human FEZ1... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions, kits, and methods relating to the human FEZ1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions, kits, and methods relating to the human FEZ1... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3621164